SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " recent " 5,631 found 🔀 AI-powered Shuffle
Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
By Dennis Thompson HealthDay ReporterFRIDAY, June 25, 2026 (HealthDay News) — People are becoming more comfortable communicating with their doctor through clinics’ patient portals. Folks use the portals to ask their doc questions and even to review the results of recent medical tests. But there are ...
PlayStation Boss Says New Console Experiences Will Involve 'Leveraging Technologies That Can Be Used in Various Forms and Locations' — and I'm Convinced He's Teasing a PS6 Handheld
Recent comments from Sony Interactive Entertainment CEO Hideaki Nishino have suggested PlayStation may move towards more hybrid, Switch-like consoles in the future to match modern on-the-go players.
Apple to Skip M6 Pro and M6 Max, Jumps to M7 Series
Apple has reportedly canceled its M6 Pro and M6 Max processors, according to a recent note from Bloomberg's Apple insider Mark Gurman. Behind the scenes, there is a significant shift in Apple's silicon rollout strategy. The company is postponing the launch of its higher-end M6 SoC variants, like the...
Meet the 'Queen of Magazine,' the retail adviser who's brought over dozen brands to the street
We caught up to Carly Ibach during a recent visit to scout out Magazine Street for another national retailer.
Opinion | Don't apply politics to scientific research
Under recently proposed rules, federal grants could be terminated midstream for reasons having little to do with science or merit.
‘It’s necessary, we need it’: Business owner welcomes increased Petersburg police presence after Father’s Day mass shooting
Petersburg police have announced a new public safety initiative to curb gun violence after several recent shootings, including a Father’s Day mass shooting in Old Towne that left five people injure…
Winter Sports Club to raise Olympian banners July 3 at Olympian Hall
The Steamboat Springs Winter Sports Club will raise banners to the rafters of Olympian Hall at Howelsen Hill to honor the area’s most recent Olympians. The event will take place from 4-5:30 p.m. on July...
Valve Quietly Walks Back Steam Machine 4K 60 FPS Performance Claims
Valve's Steam Machine has earned more than its fair share of skeptics, thanks to performance claims and more recently its unfortunate pricing. More recently, though, Valve has seemingly taken some of this criticism to heart and silently changed some of those performance claims on the Steam Machine p...
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Following IAM Union Advocacy, Kansas PERB Orders Count of Timely Cast Ballots in KU Health System Pharmacy Technician Union Election
KANSAS CITY, Kan. — Following weeks of advocacy from the IAM Union, Pharmacy Technicians, elected officials and community supporters, the Kansas Public Employee Relations Board (PERB) has ruled that 37 previously uncounted ballots will be included in the final tally of the recent union representation election involving Pharmacy Technicians at the University of Kansas (KU)
Roundup: Shift in NIL / BlackBerry transitions / Agriculture aid
More inclusive: A recent NCAA rule change is shifting name, image and likeness opportunities away from only the biggest star athletes to a wider range of student-athletes. The update gives schools more structured involvement in managing and facilitating NIL deals, which reduces some of the previous free-for-all environment. As a result, athletes who are not […]
Participating in heavy-contact youth sports, dropping out of sports linked to acts of violence
Contrary to popular belief, simply playing organized youth sports does not reduce the likelihood of committing violence in one’s lifetime, and in some cases, may increase it, according to a new study.The study, published online recently in the Sociology of Sport Journal, found that while most survey respondents — including those who played y...
Sofia Elverdin Selected as Co-Recipient of the Best Dissertation Prize From the American Political Science Association’s Women, Gender and Politics Section
Sofia Elverdin, assistant professor of politics at Washington and Lee University, was recently selected as a co-recipient of the American Political Science Association’s (APSA) Best Dissertation Pr…
Sean Hannity Explains Puffy Face in Health Update Amid Viewer Concern
Sean Hannity gave a health update after viewers expressed concern about his puffy face and raspy voice in recent Fox News telecasts.
Fox News anchor Sean Hannity addresses viewers’ concerns over appearance
Fox News host Sean Hannity addressed online chatter about his health in a social media post on Wednesday after viewers raised concerns about his appearance on the air in recent days. “Thanks …
GLP-1 and reduced cancer risk discovery earns UT Health San Antonio fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Mays Cancer Center at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual meeting in Chicago.
First-of-its-kind discovery earns UT Health San Antonio Mays Cancer Center fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Mays Cancer Center at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual meeting in Chicago.
York, Community Unite for Hands-On Environmental Science Journey
A group of students, faculty, and Southeast Queens residents recently traveled from the York College campus to the waterfront campus of Kingsborough Community College (KCC) in the Manhattan Beach neighborhood of Brooklyn to set sail in the Research Vessel CUNY1 on Jamaica Bay, and to explore a part of the Hudson Raritan Estuary system.
Myles Garrett's Rise Could Fuel T.J. Watt's Next Steelers Surge
For years, T.J. Watt and Myles Garrett have been linked in one of the NFL's defining player rivalries. Now, with Garrett pulling ahead in recent seasons and Patrick Graham arriving in Pittsburgh, Watt has fresh reasons to respond. For much of their careers, Watt's production far outpaced Garrett's. That changed in 2023 when the Cleveland Browns hired Jim Schwartz as defensive coordinator and Garrett elevated his game to another level.
Make/Films opens new Lancaster city studio in Stadium District
Make/Films — the studio that brought a story about a Garden Spot teacher to movie theater screens nationwide — recently tripled its space with a new studio.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Grading every move from the Steelers’ 2026 offseason
Did the Steelers hit the mark in one of their most pivotal offseasons in recent memory?
World Cup: can big sports events bring us together? Recent history says yes
Although fleeting, sporting events have the enduring power to crumble divisions and highlight the beauty of kinship
19 fours, 6 sixes! Vaibhav Sooryavanshi's younger brother Ashirvad Sooryavanshi hits blistering century
Young cricketer Ashirvad Sooryavanshi, just 10 years old, is making waves with his exceptional batting. He recently smashed a stunning 168 off 119 balls in a practice match, following a debut century. Despite only six months of playing, his aggressive style and big scores are drawing attention, even from his brother Vaibhav, who is currently with the Indian team.
Anthropic accused Alibaba of exploiting its AI models
Anthropic said the Chinese company interacted with Claude millions of times through 25,000 fraudulent accounts in recent months.
Binghamton University creates an open-source healthcare simulation repository
Staff from Binghamton University’s Information Technology Services and Decker College of Nursing and Health Services recently collaborated to create the SUNY Share Simulation and IPE Activity Repository.
Micron and Qualcomm forecasts ignite $400 billion AI chip stock rally
Shares of chipmakers surged late on Wednesday, adding over $400 billion in market value after strong forecasts from Micron Technology and Qualcomm breathed fresh life into Wall Street's recently waning AI stock rally.
Student From Des Plaines Wins National Science Foundation Award
Elmhurst University biochemistry major Hannah Cardenas, of Des Plaines, recently received a National Science Foundation Research Experiences for Undergraduates (NSF REU) award to participate in a 10-week summer research internship at the University of Texas at Dallas.
The NHL Is Considering Bringing More Teams to Texas
The NHL has expanded to new areas in recent years, as the North American hockey league has brought teams to Las Vegas, Utah and Seattle. More expansion could be coming. But while hockey is known for its footprint in northern U.S. states and Canada, the league is considering bringing more of it to ...
2026 NBA Draft grades: Updating pick-by-pick analysis from AJ Dybantsa, Cameron Boozer through Round 2
Adam Finkelstein has the breakdown of each pick in one of the best drafts in recent memory
Owner of Grand Ole Opry confirms it may sell country music's most iconic venues
Ryman Hospitality Properties says it is evaluating potential opportunities involving Opry Entertainment Group following recent media reports.
Khanna: ‘Progressive movement is on the ascendancy’
Rep. Ro Khanna (D-Calif.) said the “progressive movement is on the ascendancy” after recent left-wing wins throughout the country. While appearing on CNN’s “The Source with Kaitlan Collins,” Khanna…
Ryman Hospitality Properties, Inc. Addresses Recent Media Reports Regarding Opry Entertainment Group
NASHVILLE, Tenn., June 24, 2026 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in group-oriented, upscale convention center resorts and entertainment experiences, today addressed recent media reports regarding the Company’s Opry Entertainment Group (“OEG”) business. Colin Reed, Executive Chairman of Ryman Hospitality Properties said, “We are incredibly proud of our OEG business an
Mercy Helps Position St. Louis as Global Gateway for Healthcare Innovation
Mercy continues to bring innovative thought leadership to the communities it serves and beyond. Dr. Damon Broyles, Mercy vice president of clinical innovation, informatics and precision medicine, recently shared insights and helped attract new companies to St. Louis’ nationally recognized healthcare industry as part of BioSTL.
Flutter Entertainment (NYSE:FLUT) To Leave London And Trade Only In New York
Flutter Entertainment plans to delist from the London Stock Exchange and keep its ordinary shares trading only on the New York Stock Exchange. The company expects its stock to remain listed under ticker NYSE:FLUT, concentrating liquidity in the US market. The change alters how existing London holders access the stock and could reshape the shareholder base over time. Flutter Entertainment enters this shift with its stock trading at $97.85 and a mixed recent performance profile. The share...
Here's when Apple is starting mass production of the iPhone Ultra
Everything seems to be back on schedule. Recently there's been some controversy about the iPhone Ultra's release window, with a report claiming it was...
NFL Legend Jim Kelly Recovering Following Stroke
Legendary NFL quarterback Jim Kelly announced this week that he suffered a medical issue earlier this year. Kelly, 66, says that he recently suffered a stroke. However, the former Buffalo Bills great is feeling good now. Kelly opened up about his medical status while speaking with reporters at the ...
Facebook rolls out an AI companion app for creators
The new app, which is currently being tested with select creators, will have Facebook's recently-launched AI creator assistant built into it.
Program Director Shares How Articulation Agreements Benefit Meredith Pre-health Post-Baccalaureate Students
Karthik Aghoram, director of Meredith’s Pre-health Post-Baccalaureate Program, recently spoke with Inspira Advantage about the program’s articulation agreements and why they are valuable for students seeking careers in health care.
Foldable iPhone 'Ultra' Set for Production in July Despite Hinge Issues
Apple's rumored foldable iPhone "Ultra" is expected to begin mass production at the end of July, according to a new report by The Elec. Although some recent reports suggested the book-style device could be delayed due to hinge-related issues, the Korean outlet's sources indicate that Apple is still targeting a September launch as planned.
Dolphins dead last in recent power rankings
Frank Schwab of Yahoo Sports predicts a difficult 2026 for Miami.
iPhone Ultra 3D-printed hinge problems reportedly solved
Talk of a delayed launch for the upcoming iPhone Ultra now seems to have faded away, with all recent reports...
An Olympic-sized collaboration between Lake Placid, Big Apple
Commentary: Governor Kathy Hochul’s recent announcement about New York City possibly hosting the Olympics isn’t a new idea.
Howard Hahn Helps Establish Global Health Nonprofit Following International Funding Reductions | News and Publications
Kutak Rock attorney Howard Hahn recently spearheaded the formation of The GOARN Fund, Inc. (&ld...
New Guidebook Helps Puget Sound Beneficiaries Navigate Their Health Care
Great news for military communities and TRICARE beneficiaries across the Pacific Northwest: navigating military healthcare just got easier. The recently released Puget Sound Patient Guidebook is a comprehensive resource designed for local TRICARE beneficiaries throughout the region. Inside, beneficiaries can find information on enrolling in the Defense Enrollment Eligibility Reporting System, understanding TRICARE plans, locating a Military Treatment Facility (MTF), scheduling appointments, accessing online services, ordering medications and much more.
Cowboys news: How recent NFL contracts could impact Dallas players
The latest news and notes around the Dallas Cowboys
Caitlin Clark's argument with her coach went viral. How did Indy sports reporters handle the story?
To anyone who’s familiar with WNBA coverage, it’s no surprise that a recent video of a mid-game disagreement between Caitlin Clark and her coach went viral.
Dodgers Unleashing Shohei Ohtani Despite Recent Injury Concerns
The Dodgers will allow star Shohei Ohtani to hit and pitch on Wednesday vs. the Twins despite a run of complications over the last few weeks.
Rooted in History: Peoria’s Hoerr Nursery celebrates century in business
The Peoria County Board recently recognized Hoerr Nursery for its century-long run and how the family-owned company has grown through the generations.
Dartmouth Health reports $63.5 million loss at end of quarter
According to a recent filing, Dartmouth Health lost millions of dollars due to severe winter weather, inflation, and other challenges.
2026 NBA Draft Grades: Analysis for AJ Dybantsa, Darryn Peterson, Cameron Boozer, rest of first-round picks
Adam Finkelstein has the breakdown of each pick in one of the best drafts in recent memory
Bills legend Jim Kelly reveals he suffered stroke this spring
A Hall of Fame quarterback revealed he dealt with a health scare recently.
Salt Lake City to begin requiring business licenses for short-term rentals
Utah's capital city is now cracking down on recent short-term rental challenges through an ordinance that will require business licenses to operate them.
Daryl Hall reveals he recently had kidney transplant: 'Get ready for more music'
Daryl Hall is recovering after receiving a kidney from 'a very kind and generous living donor.'
Roku May Help Fox Avoid Aggregeddon
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Scrolling through links over the last week, I stumbled across this fun headline: Wow. Formula 1 (the sport, not the docu-series) is the perfect “dog not barking”. As a reminder, each week in my Streaming Ratings Report, I call out the shows that miss every viewership chart. I dub them “dogs not barking”—like the Sherlock Holmes mystery—because without any data, we forget they even exist. This is in contrast to something like, say, a film flop—cough The Mandalorian and Grogu cough—where even underperforming at the box office is widely discussed here, there and everywhere. In the US, Formula 1 is now in “no public viewership data, so not discussed” territory. After moving to Apple TV from its former home of ESPN, basically no one talks about it. Apple did publish an initial, unsourced, unsubstantiated, (dare I say unserious) datecdote claiming more folks are watching Formula 1 on Apple than ESPN, but we haven’t gotten any updates since. This stands in contrast to when the sport streamed on ESPN, and ESPN PR provided weekly viewership figures. Formula 1 was, at best, a niche sport in America—averaging 1.3 million viewers in the Big Data Plus era—but now it’s basically anonymous. (And yeah, after moving to Apple, I very, very, very much doubt its ratings increased.) Unfortunately, that story isn’t quite big enough to warrant a section in today’s “Most Important Story of the Week” column, but I wanted to call it out, because otherwise, no one else will! Certainly, no one will write articles about the silence/ratings decline, unlike when they wrote breathless articles connecting the rise in viewership to Netflix’s Drive to Survive, including Reuters just last month. (This is a topic I’ve tried to provide a moderate/nuanced/non-hyped take since 2022.) Anyway, on to this week’s issue. I was a bit worried I didn’t have a juicy topic, then the Murdochs went out and did their Murdoch thing: buying Roku. So that’s the story of the week, and it happens to touch on quite a few themes of the streaming wars and the disruption therein. I’ll cover that, plus why more consolidation in Hollywood media looks likely, more good news on the Hollywood labor front, whether we’ll see an uptick in production in Los Angeles, some Broadway and theme park news, cellphone prices going up in the third world (and possibly everywhere), and more. Subscribe Most Important Story of the Week - Another Big Media & Entertainment Merger The story of the week is clearly Fox is buying Roku for $22 billion. I read a lot of good strategy takes on why Fox bought this streaming TV device maker—and I’ll have mine below—but what fascinates me more is how this deal connects to quite a few themes of the streaming wars, linking to everything from the pace of M&A to “aggregeddon” to Netflix’s recent M&A actions/inactions to the shift to advertising from pure play streaming and more. The only topic I can’t really connect it to is my old theory, “never bet against Rupert Murdoch” because he isn’t the one who did this deal; his son Lachlan inked it. (Do I think he provided advice, even at his 95 years of age? Sure.) That plus I have one additional piece of strategy for all entertainment players, inspired by this deal. So let’s dive into all those topics, starting with why I like this deal. Roku is a Great M&A Buy
Pre-RAMpocalypse Steam Machine Pricing was ~30% Cheaper
It's no secret that Valve's Steam Machine is launching at possibly the worst moment for both PC and console gaming hardware, given the ongoing DRAM crisis, but Valve engineer, Pierre-Loup Griffais, has recently shed light on the pre-RAM crisis pricing of the Steam Machine, revealing that it was neve...
Sonic Frontiers: Definitive Edition finally announced for Nintendo Switch 2, out now, trailer
After numerous leaks, Sonic Frontiers Definitive Edition has finally been announced for Nintendo Switch 2. Not only that, but you can purchase it now. We’ve heard about this one as early as March. Initially, the game was outed by a classification rating. More recently, the release date was leaked with a few details coming shortly after that. Sonic Frontiers: Definitive...
Polymarket allegedly faked trades. Chances are slim Trump admin investigates, says sports-betting attorney
A recent Wall Street Journal investigation found that the prediction market hired influencers to stage fake trades as part of its marketing campaign to attract U.S. users.
Sporticast: Why Netflix, EA Have Their Own World Cup Games
On the 563rd Sporticast episode, hosts Jacob Feldman and Justin Birnbaum discuss some of the biggest sports business stories of the week, including a detailed breakdown of Netflix’s FIFA World Cup video game. Following Electronic Arts and FIFA’s split in 2022, both parties now have World Cup-related offerings on the market. Electronic Arts recently launched …
Polls open as New Yorkers vote in several contested congressional races
Several contests feature open seats, high-profile endorsements and millions of dollars in campaign spending, making this one of the most consequential primary days in recent years.
9 of the best technology conspiracy theories
From covert government surveillance to wireless signals transmitting viruses, tech-centric conspiracy theories have been propagating wildly in recent years. Most of them are completely unfounded — but not all.
Tetanus cases are rising. How to prevent getting this potentially fatal disease
Recent CDC reports found dozens of tetanus deaths since 2011 and four cases in children in 2024. CNN’s Dr. Leana Wen explains how people can protect themselves.
Is Lowe's (LOW) Entertainment-Focused Loyalty Push a New Edge in Customer Engagement?
Lowe's Companies, Inc. recently announced a multi-year partnership with Live Nation Entertainment to offer MyLowe's Rewards and MyLowe's Pro Rewards members exclusive live music benefits, including concert perks and amphitheater tailgate experiences at select venues starting this summer. This expansion of the loyalty program into entertainment experiences highlights Lowe's effort to deepen customer engagement beyond the store and into members' leisure time. Next, we’ll explore how this...
NY-7 candidates make final pitch to voters before Election Day
The race has narrowed in recent days.
Santana: Politician Spending Accounts Fuel Banana Republic Politics Across OC
Despite recent grand jury warnings, OC Supervisors tomorrow are ready to vote to keep spending and creating multi-million dollar, taxpayer-funded discretionary spending accounts.
Here's Why AMC Entertainment (AMC) Fell More Than Broader Market
In the closing of the recent trading day, AMC Entertainment (AMC) stood at $2.74, denoting a -3.04% move from the preceding trading day.
Mississippi Board of Mental Health tabs new leadership+
The Mississippi Board of Mental Health selected Teresa Mosley as chair and Dr. Sara Gleason as vice chair during a recent meeting.
Lancaster General Health sells downtown Lititz office building for $8.1M
The new owners of a historic mill that most recently served as Penn Medicine Lancaster General Health’s administrative offices will look to revitalize the building as a mix of retail,
Business Elite Awards Honors Berkeley College Leader Among ‘40 Under 40’ Visionaries
Business Elite Awards, an international organization dedicated to recognizing outstanding leadership and professional excellence, recently honored
Real Estate Partner Sara Neva Receives Another Top Accolade, Named 40 Under 40 Leader by San Diego Business Journal
Procopio Real Estate Partner Sara Neva has been named to the 2026 40 Under 40 Leaders list by the San Diego Business Journal, the third time she's earned Real Estate Partner Sara Neva has earned her most recent recognition, named to the San Diego Business Journal list for 2026.
Price of San Diego: Rising cost of youth sports leaving some kids on the sideline
A recent study by the Aspen Institute’s Project Play shows that family spending on youth sports has increased by 46% since 2019. Making it out of reach for many low-income families.
2 Most Unexpected Heroes To Return in Avengers: Secret Wars
Two unexpected characters could have major roles in Avengers: Secret Wars, per a new rumor. While the recent report from a well-known entertainment scooper’s claim has yet to receive official confirma...
Digital Health Institute welcomes French delegation to explore pathways to collaboration
The Houston Methodist-Rice Digital Health Institute recently welcomed Frank Marchetti, Consul General of France in Houston, and his team to discuss health care innovation and avenues for international collaboration.
KSU master’s graduates benefit from NIH-funded bridge program
Recent Kennesaw State University graduate April Ford engaged in a program designed to help master’s students in the College of Science and Mathematics gain the experience they needed to pursue doctoral degrees elsewhere. She’ll stand as an example of the Peach State Bridges to the Doctorate program’s effectiveness, having earned her Master of Science in Integrative Biology (MSIB) and acceptance into a Ph.D. program. Ford, Jojo Croffie, and Lindsey Knight all earned their MSIB degrees, and thanks to enrichment through the Peach State Bridges to the Doctorate program, each will start a Ph.D. in the fall.
Starmer announces he'll resign as U.K. prime minister
Burnham's recent victory in a special parliamentary election prompted Starmer's decision
Morning Sports: June 22, 2026
Beck Haswell of Sheridan HS Wins 2026 Boys Milward Simpson Award: A recent Sheridan HS grad and 2-sport athlete has been named the top overall male athlete from the graduating class of 2026. Beck Haswell was named the boys winner of the 2026 Milward Simpson Award, becoming the 6th Bronc to do so. Haswell was […]
SAFES grants to address Critical Issues Initiatives in College of Ag Sciences
Penn State’s College of Agricultural Sciences, through its Institute for Sustainable Agricultural, Food and Environmental Science, known as SAFES, recently announced its latest awards to accelerate the advancement of its Critical Issues Initiatives.
First Business Bank Funds $1MM Factoring Facility for Transportation Company Growth
First Business Bank’s accounts receivable financing team recently closed a $1 million factoring facility to support the continued growth of a transportation
First Business Bank Funds $1MM Factoring Facility for Transportation Company Growth
First Business Bank’s accounts receivable financing team recently closed a $1 million factoring facility to support the continued growth of a transportation
OSS Names Paul Averna VP of Business Development
Averna most recently served as vice president of VX Marine and earlier in leadership roles at Cubic Defense.
Basketball powerhouse Putnam Science Academy (Conn.) closing down
Basketball powerhouse Putnam Science Academy (Conn.) is reportedly shutting down due to financial crisis following recent reports.
Construction starts on 7th Highlands Oncology Center
Springdale-based cancer-care provider Highlands Oncology recently broke ground on a five-story, 125,000-square-foot cancer-care center along Interstate 49 in the Pinnacle Hills area of Rogers. The Rogers Cancer Center at 4872...
Opinion: Is the role of the Alaska Board of Fisheries sustainability or politics?
The recent decision by the Alaska attorney general’s office to overturn several Area M management proposals raises serious concerns about the state’s commitment to sustainable fisheries management.
Albany County executive details input on withdrawn bus terminal plan
Opponents of the plan had raised traffic and environmental concerns at recent meetings.
When A Favicon Becomes The Entire Website
Putting hidden data in places where few expect it can be a fun hobby or even a professional career. In the case of [Tim Wehrle] it’s just the former. His most recent project in this area uses…
Anti-Myles Garrett commentary starts to leak out of Cleveland
A recent column out of Cleveland slighted the Defensive Player of the Year’s leadership.
St. Peter's Health Partners, Ellis Medicine ending partnership, merger talks
Merger talks had been in the works for years, with Ellis releasing a statement as recently as this February outlining what a full merger could look like.
Raising the minimum wage has been a big political winner. Now it's running into resistance
Raising the minimum wage has been a progressive policy winner at the ballot box, but recent losses suggest an economic mood slowing its political momentum.
ALJ students visit elementary schools for Science Enrichment Days
CLARK — Arthur L. Johnson High School’s Science National Honor Society recently brought energy and excitement to third
The surprising science of how fatherhood changes the brain
Recent studies suggest that, like mothers, fathers may undergo a profound shift in their biology and brains in preparation for and response to the responsibilities of parenthood.
Cities and Schools Are Testing Wastewater for Illicit Drugs
The White House recently endorsed monitoring sewage for evidence of drug use. Critics fear such efforts could violate privacy and stigmatize neighborhoods.
LSU Health Foundation names new managing director; contractor hires for new national sales team
Take a look at some of the recent promotions and new hires announced at south Louisiana businesses.
LSU Health Foundation names new managing director; contractor hires for new national sales team
Take a look at some of the recent promotions and new hires announced at south Louisiana businesses.
Want to Slow Your Aging? Multivitamins, Diet, and Fitness May Help
Recent research has explored the possible effects of diet, daily multivitamins, and cardiorespiratory fitness on aging. Learn about the findings here.
Citizen science in Japan’s Ogasawara Islands spotlights ties between ships and birds
A recent study has shed new light on seabirds’ tendencies to follow ships near the island chain and highlights the role wildlife enthusiasts can play in research.
April Coffee is a business coach and an advocate for unification around scholarships
By Andy Furman NKyTribune staff writer April Coffee says she was quiet, real quiet – almost shy – when she attended Scott High School. Really? If so, she fooled the Covington Rotary Club, as she had them mesmerized on every word during her noontime presentation recently at the Radisson Hotel. “I’m a Business Coach,” she...
Lakers linked to Luka Doncic satisfying trade with Mavericks
The Los Angeles Lakers would appease their star point guard in a recent trade idea.
Miami Dolphins Fans Opinion Of The Roster Following OTA’s
Miami Dolphins fans share both the positive and negative takeaways from the team's recent OTAs.
Nintendo Switch Sports Resort confirms 100 Pin Bowling, here's a first look
Nintendo Switch Sports Resort, which was recent announced, has confirmed that 100 Pin Bowling will be included. Nintendo itself shared the news, posting a screenshot on its Japanese website. 100 Pin Bowling was a part of the original Wii Sports Resort. It’s still ultimately about bowling, but the mode is set up in a triangular formation and obviously has you...
Cardinal Health (CAH) Stock Could Be 9.6% Undervalued Despite Rich P/E Signals
Cardinal Health (CAH) has drawn investor attention after its stock closed at $221.77. This has put recent performance and current valuation metrics in focus for those tracking large U.S. healthcare distributors. See our latest analysis for Cardinal Health. While Cardinal Health’s share price slipped around 2% in the latest session, the 30-day share price return of 10.55% and 1-year total shareholder return of 37.25% sit alongside a very large 5-year total shareholder return of 334.47%. Taken...